Company: SXTPW
Filing Date: 2025-09-02
Form Type: DEFR14A
Source: 0001213900-25-082789
Chunk: 32

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-02
Form: DEFR14A
Chunk 32
---
 stock,                                                                  
 of which includes (i) 234 shares of common stock held in the name of Mr. Toovey, and (ii) 284 shares underlying fully vested options 
 exercisable into common stock at a per share exercise price of $318.00.                                                              |

| (8) | Mr. Field beneficially owns a total of 518 shares of common stock,                                                                   
 of which includes (i) 167 shares of common stock held by the Field Family Trust, of which Mr. Field is a trustee and has control     
 over the voting and disposition of the shares of common stock held by the Field Family Trust, (ii) 67 shares of common stock held    
 in the name of Mr. Field, and (iii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise 
 price of $318.00.                                                                                                                    |

22 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Under the Company’s policies and procedures for the review of related person transactions the Audit Committee reviews related person transactions in which we are or will be a participant to determine if they are in the best interests of our stockholders and the Company. Transactions, arrangements or relationships or any series of similar transactions, arrangements or relationships in which a related person had or will have a material interest and that exceed $120,000 are subject to the Audit Committee’s review. Any member of the Audit Committee who is a related person with respect to a transaction under review may not participate in the deliberation or vote respecting approval or ratification of the transaction. Related persons are directors, director nominees, executive officers, holders of 5% or more of our voting stock and their immediate family members. Immediate family members are spouses, parents, stepparents, children, stepchildren, siblings, daughters-in-law, sons-in-law and any person, other than a tenant or domestic employee, who resides in the household of a director, director nominee, executive officer or holder of 5% or more of our voting stock. After its review, the Audit Committee may approve or ratify the transaction. Other than as disclosed below, and except for the regular salary and bonus payments made to our directors and officers in the ordinary course of business as described in the section “ Executive Compensation,” there have been no transactions since January 1, 2023 or any currently proposed transaction or series of similar transactions to which the Company was or is to be a party, in which the amount involved exceeds USD$120,000 and in